Drug intelligence / Profile preview

D.Grotin

Development stage: Unknown
Lead developer: Grievers Remedies
Modality: Recombinant Proteins and Enzymes, Small Molecules

Overview

D.Grotin is a specialized nutritional protein supplement developed and marketed by Grievers Remedies for the dietary management of diabetes. Formulated as a powder, it contains a blend of proteins, essential vitamins, and minerals designed to meet the specific nutritional requirements of diabetic patients. The product is intended to support muscle maintenance, provide sustained energy, and assist in maintaining balanced nutrition without causing significant spikes in blood glucose levels. It is typically used as a dietary adjunct to standard diabetes care.

Brand names: D.GrotinD-Grotin
Other names: D.Grotin Protein Powder

Targets

LTCC (Voltage-gated calcium channel (L-type))PDE4 (Phosphodiesterase 4A1)

Beyond the preview

Go deeper on D.Grotin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D.Grotin.

Explore the full profile